NCT06001502

Brief Summary

The objective of this study is to investigate the effect of VR on post-operative pain and anxiety management in cardiac surgery patients undergoing a coronary artery bypass grafting (CABG) procedure. Participants in the intervention group will receive a 20 minute session with the head mounted VR device on post-operative days 1,2 and 3. Participants in the control group will be treated with conventional post-operative care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

July 10, 2024

Status Verified

July 1, 2024

Enrollment Period

1.6 years

First QC Date

August 14, 2023

Last Update Submit

July 9, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Numeric Rating Scale (NRS)

    The NRS score is a numeric scale in which individuals rate pain from 0 (no pain) tot 10 (worst pain). This is a subjective score which is assessed verbally and used frequently in standard clinical care in multiple medical specialties.

    Post-operative days 1,2 and 3 directly after the VR intervention

  • State- Trait Anxiety Inventory 6 questionnaire

    The STAI-6 questionnaire is a validated psychological inventory designed to measure worry, tension and anxiety in an individual. It is a shortend version of the STAI score

    Post-operative days 1,2 and 3 directly after the VR intervention

  • Quality of Recovery-15

    The QoR-15 questionnaire is a clinical validated instrument to measure post-operative quality of recovery.

    Post-operative days 1,2 and 3 directly after the VR intervention

Study Arms (2)

Virtual Reality group

EXPERIMENTAL

Virtual Reality distraction therapy on post-operative days 1,2 and 3.

Device: Virtual Reality distraction therapy

Control Group

NO INTERVENTION

Conventional post-operative pain and anxiety management

Interventions

The VR device simulates a 3-dimensional virtual enviroment, seeking to immerse the user in virtual surroundings

Also known as: Healthy Mind VR device
Virtual Reality group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years or older with written informed consent
  • Patients undergoing surgical CABG

You may not qualify if:

  • Major comorbidities besides coronary artery disease
  • Complicated surgical procedure
  • Hearing and/or visual impairments
  • Psychiatric impairments
  • Complaints of vomiting and nausea
  • History of epilepsy
  • Claustrophobia
  • Facial wounds and skin defects at site of application
  • Patients placed in clinical isolation
  • Readmission to the intensive care unit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Academic Medical Center

Amsterdam, North Holland, 1105 AZ, Netherlands

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Jolanda Kluin, MD, PhD

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sulayman El Mathari, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor dr. J. Kluin, MD, PhD

Study Record Dates

First Submitted

August 14, 2023

First Posted

August 21, 2023

Study Start

January 1, 2023

Primary Completion

August 1, 2024

Study Completion

September 1, 2024

Last Updated

July 10, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Upon request available.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After publication
Access Criteria
Upon request available.

Locations